1. Home
  2. MNDO vs KTTA Comparison

MNDO vs KTTA Comparison

Compare MNDO & KTTA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo MIND C.T.I. Ltd.

MNDO

MIND C.T.I. Ltd.

HOLD

Current Price

$1.06

Market Cap

21.2M

Sector

Technology

ML Signal

HOLD

Logo Pasithea Therapeutics Corp.

KTTA

Pasithea Therapeutics Corp.

HOLD

Current Price

$0.92

Market Cap

18.9M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
MNDO
KTTA
Founded
1995
2020
Country
Israel
United States
Employees
N/A
4
Industry
EDP Services
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
21.2M
18.9M
IPO Year
2000
N/A

Fundamental Metrics

Financial Performance
Metric
MNDO
KTTA
Price
$1.06
$0.92
Analyst Decision
Strong Buy
Analyst Count
0
1
Target Price
N/A
$3.00
AVG Volume (30 Days)
34.3K
465.0K
Earning Date
05-08-2026
05-14-2026
Dividend Yield
20.95%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$8.57
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.98
$0.28
52 Week High
$1.68
$2.06

Technical Indicators

Market Signals
Indicator
MNDO
KTTA
Relative Strength Index (RSI) 38.22 69.44
Support Level $1.03 $0.68
Resistance Level $1.23 $1.31
Average True Range (ATR) 0.04 0.06
MACD 0.00 0.02
Stochastic Oscillator 28.57 82.17

Price Performance

Historical Comparison
MNDO
KTTA

About MNDO MIND C.T.I. Ltd.

MIND C.T.I. Ltd develops, manufactures, markets, and implements real-time and off-line convergent billing and customer care software solutions. It derives revenue from the sale of software products and services in two reportable segments, namely Billing and Related Services, which derives key revenue, and Messaging. The company has three product lines: Product Line A- billing and customer care solutions for service providers; Product Line B - call accounting and call management solutions for enterprises; and Product Line C - mobile messaging, communication, and payment solutions. Geographically, the company operates in the Americas, Europe, Asia Pacific and Africa, and Israel. It earns maximum revenue from Europe.

About KTTA Pasithea Therapeutics Corp.

Pasithea Therapeutics Corp is a biotechnology company. It is focused on the discovery, research, and development of treatments for central nervous system (CNS) disorders and other diseases, including RASopathies and certain cancers. It leveraging in the fields of neuroscience, translational medicine, and drug development. Its pipeline includes Neurofibromatosis Type 1, Amyotrophic Lateral Sclerosis (ALS), Multiple Sclerosis (MS), and Schizophrenia. Companies pipelines includes PAS-004 (Macrocyclic Small Module[MEK1/2]), PAS-003 (Monoclonal antibody),PAS-001 (Small Module).

Share on Social Networks: